1. In this randomized controlled trial, among patients with moderately to severely active ulcerative colitis, tulisokibart, a monoclonal antibody directed...

1. In this randomized controlled trial, among patients with severe hypoxemia, long-term oxygen therapy used for 24 hours per day...

1. In this randomized controlled trial, among patients with mixed hyperlipidemia, plozasiran significantly reduced fasting triglyceride levels compared with placebo....

1. In this randomized controlled trial, among ischemic stroke patients treated with intravenous thrombolysis, it was found that adjunctive intravenous...

1. In this randomized controlled trial, among traumatic brain injury (TBI) patients with anemia, a liberal red-cell transfusion strategy resulted...